Medicamen Organics Limited IPO Detail
Medicamen Organics Limited was incorporated in 1995 and develops, manufactures, and distributes pharmaceutical dosages including generic dosages in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders for the Government (including State Governments and Central Governments) and private entities as a contract manufacturer/third party manufacturer.
The company's product list comprises 84 products and offers a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).
The company's products are marketed throughout India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.
The company has two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering an area of 21,536 Sq. Ft. As on September 30, 2023, the company has entered into contract manufacturing with 38 domestic partners and 12 merchant exporters.
As of September 30, 2023, the company employed a total of 116 people.
Company Promoters
Mr. Bal Kishan GuptaIPO Details
| IPO Opening Date | Jun 21, 2024 |
| IPO Closing Date | Jun 25, 2024 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹32 - 34 per equity share |
| Market Lot | 4000 Shares |
| Min Order Quantity | 4000 Shares |
| Listing At | NSE SME |
| Issue Size | ₹10.54 Cr |
| Fresh Issue | ₹10.54 Cr |
| Offer for Sale | - |
| Retail Portion | 35% |
IPO Subscription (Bidding Detail)
| AS On | QIB | SHNI | BHNI | NII | RII | TOTAL |
|---|---|---|---|---|---|---|
| Day 1 | 1.01x | 0.00x | 0.00x | 37.20x | 92.26x | 54.49x |
| Day 2 | 1.42x | 0.00x | 0.00x | 125.83x | 348.14x | 201.79x |
| Day 3 | 173.03x | 0.00x | 0.00x | 1343.83x | 1309.77x | 993.56x |
IPO Tentative Timetable
The Medicamen Organics Limited IPO open date is Jun 21, 2024, and the close date is Jun 25, 2024. The issue may list on Jun 28, 2024.
| IPO Open Date | Jun 21, 2024 |
| IPO Close Date | Jun 25, 2024 |
| Basis of Allotment Date | Jun 26, 2024 |
| Initiation of Refunds | Jun 27, 2024 |
| Credit of Shares to Demat Account | Jun 27, 2024 |
| IPO Listing Date | Jun 28, 2024 |
IPO Lot Size
The Medicamen Organics Limited IPO market lot size is 4000 shares. A retail-individual investor can apply for up to 1 lots (4000 shares or ₹136000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 4000 | ₹136000 |
| Maximum | 1 | 4000 | ₹136000 |
IPO Promoter Holding
| Pre Issue Share Holding | 81.21% |
| Post Issue Share Holding |
Company Financials:
For the year/period ended (₹ in Lakhs)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 2634.37 | 2505.96 | 29.81 |
| 31-Mar-22 | 2707.21 | 2118.67 | 9.23 |
| 31-Mar-23 | 3211.98 | 2296.24 | 95.78 |
| 30-Sep-23 | 3450.88 | 1132.60 | 129.11 |
Objects of the Issue:
The company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Funding of expenses proposed to be incurred towards Product registration in the international markets;
- Plant updation and increase in production capacity;
- Funding working capital requirements of our Company; and
- General Corporate Purposes.
Medicamen Organics Limited IPO Registrar:
KFin Technologies Limited
Medicamen Organics Limited IPO Lead Manager(s):
GYR Capital Advisors Private Limited
Company Contact Information:
Medicamen Organics Limited
10 Community Centre,
No 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
